Alterations in insulin pathway genes, such as <i>PTEN</i>, <i>FOXO</i>, and <i>PIK3CA</i>, are mutated in up to 32%, 15%, and 11% of localized prostate tumors, respectively. Here, INS is linked to prostate neoplasm.